Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Allen Insider Profile
4 Followers
Andrew Allen, Executive Vice President of Clinical and Pre-Cl... at Clovis Oncology, holds 2.43M shares in Gritstone bio (Ticker: GRTSQ), holds 0.00 shares in Sierra Oncology (Ticker: SRRA), holds 20.56K shares in Epizyme (Ticker: EPZM).
Andrew Allen Clovis Oncology (CLVSQ)Executive Vice President of Clinical and Pre-Cl...
Clovis Oncology (CLVSQ)
Executive Vice President of Clinical and Pre-Cl...
Ranked #42,810 out of 99,797 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+11.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Allen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Allen
Andrew Allen's Trading History
Clovis Oncology
Jan 20, 2015
―
Uninformative Sell
5.25M
$1.53K
Sierra Oncology
Jul 01, 2022
―
Uninformative Sell
90.75K
$0.00
Gritstone bio
Jun 26, 2024
President & CEO, Director
Uninformative Sell
―
$29.22K
TCR2 Therapeutics
―
―
―
―
Adaptimmune Therapeutics
―
Director
―
―
Epizyme
Jun 15, 2021
―
Uninformative Buy
―
$30.22K
List of latest transactions for each holding click on a transaction to see Andrew Allen's performance on stock
You May Also Like
Andrew Allen insider profile FAQ
What is the percentage of profitable transactions made by Andrew Allen?
The percentage of profitable transactions made by Andrew Allen is 50%.
What is the average return per transaction made by Andrew Allen?
The average return per transaction made by Andrew Allen is 11.90%.
What stocks does Andrew Allen hold?
Andrew Allen holds: CLVSQ, SRRA, GRTSQ, TCRR, ADAP, EPZM stocks.
What was Andrew Allen’s latest transaction?
Andrew Allen latest transaction was an Uninformative Sell of ―.
What was Andrew Allen's most profitable transaction?
Andrew Allen’s most profitable transaction was an Informative Sell of GRTSQ stock on May 17, 2024. The return on the trade was 96.60%.
What is Andrew Allen's role in Clovis Oncology?
Andrew Allen's role in Clovis Oncology is Executive Vice President of Clinical and Pre-Cl....
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.